Livzon Pharmaceutical Outlines Board and Committee Structure

Livzon Pharmaceutical Group ( (HK:1513) ) has shared an announcement.

Livzon Pharmaceutical Group has disclosed the current composition of its board of directors and the membership of its five key board committees, reaffirming its corporate governance structure. The board comprises executive, non-executive, independent and employee representative directors, with Zhu Baoguo serving as chairman and Tang Yanggang as vice chairman.

The announcement details which directors chair or sit on the Audit, Remuneration and Assessment, Nomination, Strategy, and Environmental, Social and Governance committees, underscoring a separation of oversight responsibilities. By clarifying roles and committee assignments, the company signals a structured approach to governance, risk management and strategic decision-making that is relevant for investors and other stakeholders monitoring board effectiveness.

The most recent analyst rating on (HK:1513) stock is a Sell with a HK$22.99 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.

More about Livzon Pharmaceutical Group

Livzon Pharmaceutical Group Inc. is a China-based pharmaceutical company engaged in the research, development, production and sale of medicines and related healthcare products. The company operates under a board structure that includes executive, non-executive, independent and employee representative directors, supported by multiple specialized board committees overseeing governance and strategic matters.

Average Trading Volume: 774,806

Technical Sentiment Signal: Hold

Current Market Cap: HK$29.76B

For an in-depth examination of 1513 stock, go to TipRanks’ Overview page.